Elago, Belmar L.

HRN: 13-59-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFTAZIDIME 1GM (VIAL)
11/14/2023
11/20/2023
IVT
1g
Q8
CAP MR
Waiting Final Action 
11/18/2023
CEFUROXIME 500MG (TAB)
11/18/2023
11/25/2023
PO
500mg
OD
CAPMR
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: